|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saji H, Okada M, Tsuboi M, Nakajima R,
Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, et al:
Segmentectomy versus lobectomy in small-sized peripheral
non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre,
open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet. 399:1607–1617. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Meir H, Kenter GG, Burggraaf J, Kroep
JR, Welters MJ, Melief CJ, van der Burg SH and van Poelgeest MI:
The need for improvement of the treatment of advanced and
metastatic cervical cancer, the rationale for combined
chemo-immunotherapy. Anticancer Agents Med Chem. 14:190–203. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perkins V, Moore K, Vesely S, Matsuo K,
Mostofizadeh S, Sims TT, Lea J, Barnes D, Chen S, Carlson M, et al:
Incorporation of whole pelvic radiation into treatment of stage IVB
cervical cancer: A novel treatment strategy. Gynecol Oncol.
156:100–106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chopra S, Mangaj A, Sharma A, Tan LT,
Sturdza A, Jürgenliemk-Schulz I, Han K, Huang F, Schmid MP, Fokdal
L, et al: Management of oligo-metastatic and oligo-recurrent
cervical cancer: A pattern of care survey within the EMBRACE
research network. Radiother Oncol. 155:151–159. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mangaj A, Chopra S and Nout RA: Defining
the role of high-dose radiation in oligometastatic &
oligorecurrent cervical cancer. Indian J Med Res. 154:303–318.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grigsby PW, Siegel BA and Dehdashti F:
Lymph node staging by positron emission tomography in patients with
carcinoma of the cervix. J Clin Oncol. 19:3745–3749. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singh V, Gor D, Azad S, Ricca A, Xu Y and
Meghal T: Dysphagia as a rare presentation of cervical cancer with
mediastinal metastasis. Eur J Case Rep Intern Med.
9:0031362022.PubMed/NCBI
|
|
9
|
Plentl AA and Friedman EA: Lymphatic
system of the female genitalia. The morphologic basis of oncologic
diagnosis and therapy. Major Probl Obstet Gynecol. 2:1–223.
1971.PubMed/NCBI
|
|
10
|
Shibayama T, Hayashi A, Toki M, Kitahama
K, Ho YJ, Kato K, Yamada T, Kawamoto S, Kambayashi K, Ochiai K, et
al: Combination immunohistochemistry for CK5/6, p63, GATA6, and
HNF4a predicts clinical outcome in treatment-naïve pancreatic
ductal adenocarcinoma. Sci Rep. 14:155982024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vahadane A, Sharma S, Mandal D, Dabbeeru
M, Jakthong J, Garcia-Guzman M, Majumdar S and Lee CW: Development
of an automated combined positive score prediction pipeline using
artificial intelligence on multiplexed immunofluorescence images.
Comput Biol Med. 152:1063372023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu QQ, Li QJ, Xu Z, Lan LL, Hou Z, Liu J,
Lu L, Chen YY, Chen RZ and Wen X: Prognostic value of the
immunohistochemical score based on four markers in head and neck
squamous cell carcinoma. Front Immunol. 14:10768902023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Benevolo M, Mottolese M, Marandino F,
Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini
P, Donnorso RP and Vocaturo A: Immunohistochemical expression of
p16(INK4a) is predictive of HR-HPV infection in cervical low-grade
lesions. Mod Pathol. 19:384–391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Evans MF, Peng Z, Clark KM, Adamson CS, Ma
XJ, Wu X, Wang H, Luo Y and Cooper K: HPV E6/E7 RNA in situ
hybridization signal patterns as biomarkers of three-tier cervical
intraepithelial neoplasia grade. PLoS One. 9:e911422014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abu-Rustum NR, Yashar CM, Bean S, Bradley
K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, et al:
NCCN guidelines insights: Cervical cancer, version 1.2020. J Natl
Compr Canc Netw. 18:660–666. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beyaz F, Verhoeven RLJ, Schuurbiers OCJ,
Verhagen AFTM and van der Heijden EHFM: Occult lymph node
metastases in clinical N0/N1 NSCLC; A single center in-depth
analysis. Lung Cancer. 150:186–194. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du R, Li L, Ma S, Tan X, Zhong S and Wu M:
Lymph nodes metastasis in cervical cancer: Incidences, risk
factors, consequences and imaging evaluations. Asia Pac J Clin
Oncol. 14:e380–e385. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han X, Wen H, Ju X, Chen X, Ke G, Zhou Y,
Li J, Xia L, Tang J, Liang S and Wu X: Predictive factors of
para-aortic lymph nodes metastasis in cervical cancer patients: A
retrospective analysis based on 723 para-aortic lymphadenectomy
cases. Oncotarget. 8:51840–51847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ming Y and Wu N, Qian T, Li X, Wan DQ, Li
C, Li Y, Wu Z, Wang X, Liu J and Wu N: Progress and future trends
in PET/CT and PET/MRI molecular imaging approaches for breast
cancer. Front Oncol. 10:13012020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Onal C, Oymak E, Findikcioglu A and Reyhan
M: Isolated mediastinal lymph node false positivity of
[18F]-fluorodeoxyglucose-positron emission tomography/computed
tomography in patients with cervical cancer. Int J Gynecol Cancer.
23:337–342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Noji T, Kondo S, Hirano S, Tanaka E,
Suzuki O and Shichinohe T: Computed tomography evaluation of
regional lymph node metastases in patients with biliary cancer. Br
J Surg. 95:92–96. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Wang Z, Shao H, Qu D, Liu J and Yao
L: Improving CT detection sensitivity for nodal metastases in
oesophageal cancer with combination of smaller size and lymph node
axial ratio. Eur Radiol. 28:188–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
King MJ, Hectors S, Lee KM, Omidele O,
Babb JS, Schwartz M, Tabrizian P, Taouli B and Lewis S: Outcomes
assessment in intrahepatic cholangiocarcinoma using qualitative and
quantitative imaging features. Cancer Imaging. 20:432020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Wu C, Du J, Xiao Z, Lv F and Liu
Y: Prediction of recurrence risk factors in patients with
early-stage cervical cancers by nomogram based on MRI handcrafted
radiomics features and deep learning features: A dual-center study.
Abdom Radiol (NY). 49:258–270. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakamura K, Okumura Y, Kodama J, Hongo A,
Kanazawa S and Hiramatsu Y: The predictive value of measurement of
SUVmax and SCC-antigen in patients with pretreatment of primary
squamous cell carcinoma of cervix. Gynecol Oncol. 119:81–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu J, Wang W, Wang Y, Liu C and Wang P:
The role of squamous cell carcinoma antigen (SCC Ag) in outcome
prediction after concurrent chemoradiotherapy and treatment
decisions for patients with cervical cancer. Radiat Oncol.
14:1462019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao X, Yao J, Jia M, Shen X, Zhang J and
Ju S: Serum CCAT2 as a biomarker for adjuvant diagnosis and
prognostic prediction of cervical cancer. J Ovarian Res. 15:202022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Olawaiye AB, Baker TP, Washington MK and
Mutch DG: The new (version 9) American joint committee on cancer
tumor, node, metastasis staging for cervical cancer. CA Cancer J
Clin. 71:287–298. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saleh M, Virarkar M, Javadi S, Elsherif
SB, de Castro Faria S and Bhosale P: Cervical cancer: 2018 revised
international federation of gynecology and obstetrics staging
system and the role of imaging. AJR Am J Roentgenol. 214:1182–1195.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tewari KS, Sill MW, Long HJ 3rd, Penson
RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitai
MM, et al: Improved survival with bevacizumab in advanced cervical
cancer. N Engl J Med. 370:734–743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gadducci A, Tana R, Cosio S and Cionini L:
Treatment options in recurrent cervical cancer (Review). Oncol
Lett. 1:3–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scatchard K, Forrest JL, Flubacher M,
Cornes P and Williams C: Chemotherapy for metastatic and recurrent
cervical cancer. Cochrane Database Syst Rev.
10:CD0064692012.PubMed/NCBI
|
|
33
|
Kitagawa R, Katsumata N, Shibata T, Kamura
T, Kasamatsu T, Nakanishi T, Nishimura S, Ushijima K, Takano M,
Satoh T and Yoshikawa H: Paclitaxel plus carboplatin versus
paclitaxel plus cisplatin in metastatic or recurrent cervical
cancer: The open-label randomized phase III trial JCOG0505. J Clin
Oncol. 33:2129–2135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bonilla CE, Zapata Laguado M and Paez
Quintero H: Concurrent chemoradiation for mediastinal
oligometastases from cervical cancer: A potentially curative
treatment. Cureus. 12:e105962020.PubMed/NCBI
|
|
35
|
Park HJ, Chang AR, Seo Y, Cho CK, Jang WI,
Kim MS and Choi C: Stereotactic body radiotherapy for recurrent or
oligometastatic uterine cervix cancer: A cooperative study of the
Korean radiation oncology group (KROG 14-11). Anticancer Res.
35:5103–5110. 2015.PubMed/NCBI
|
|
36
|
Kanzaki R, Higashiyama M, Okami J and
Kodama K: Surgical treatment for patients with solitary metastasis
in the mediastinal lymph node from renal cell carcinoma. Interact
Cardiovasc Thorac Surg. 8:485–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin H, Zhang H, Cheng Y and Zhang C:
Solitary metastasis in the mediastinal lymph node after radical
nephrectomy for clear cell renal cell carcinoma: A case report and
literature review. Front Oncol. 10:5931422020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mori Y, Sano Y, Sugimoto R, Sakao N, Ryuko
T, Takeda M, Kitazawa R, Yukumi S and Izutani H: Mediastinal and
hilar lymph node metastases from renal cell carcinoma with
concomitant lung carcinoma: A rare case with unique diagnostic
challenges. Acta Med Okayama. 76:225–228. 2022.PubMed/NCBI
|
|
39
|
Disis ML: Mechanism of action of
immunotherapy. Semin Oncol. 41 (Suppl 5):S3–S13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Song Y, Du W, Gong L, Chang H and
Zou Z: Tumor-associated macrophages: An accomplice in solid tumor
progression. J Biomed Sci. 26:782019. View Article : Google Scholar : PubMed/NCBI
|
